Working... Menu

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03487198
Recruitment Status : Terminated (In consideration of the progress now and the expected enrollment in the next few years,the NDA will not be acquired before the patent went out.)
First Posted : April 3, 2018
Last Update Posted : May 10, 2019
Information provided by (Responsible Party):
Otsuka Beijing Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 25, 2019
  Actual Study Completion Date : March 25, 2019